Abstract
IntroductionUp to 40% of patients with inflammatory bowel disease (IBD) also suffer with osteoporosis.1 Receptor activator of NF-kB ligand (RANKL) promotes the formation of bone resorbing osteoclasts and is linked...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
